Colgate-Palmolive (NYSE:CL) Shares Sold by Bartlett & CO. Wealth Management LLC

Bartlett & CO. Wealth Management LLC cut its position in Colgate-Palmolive (NYSE:CL) by 2.3% during the fourth quarter, HoldingsChannel.com reports. The fund owned 106,438 shares of the company’s stock after selling 2,471 shares during the period. Bartlett & CO. Wealth Management LLC’s holdings in Colgate-Palmolive were worth $9,676,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in CL. XTX Topco Ltd purchased a new stake in Colgate-Palmolive in the second quarter valued at $423,000. Mount Yale Investment Advisors LLC purchased a new stake in Colgate-Palmolive in the second quarter valued at $421,000. EverSource Wealth Advisors LLC grew its stake in shares of Colgate-Palmolive by 79.7% in the second quarter. EverSource Wealth Advisors LLC now owns 3,504 shares of the company’s stock valued at $348,000 after buying an additional 1,554 shares in the last quarter. Evergreen Capital Management LLC grew its stake in shares of Colgate-Palmolive by 4.2% in the second quarter. Evergreen Capital Management LLC now owns 3,490 shares of the company’s stock valued at $339,000 after buying an additional 141 shares in the last quarter. Finally, BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp grew its stake in shares of Colgate-Palmolive by 59.9% in the second quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 149,787 shares of the company’s stock valued at $14,535,000 after buying an additional 56,103 shares in the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the company’s stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the sale, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at $3,456,283.86. This represents a 55.29 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 0.34% of the company’s stock.

Colgate-Palmolive Stock Down 0.8 %

NYSE CL opened at $87.53 on Thursday. Colgate-Palmolive has a twelve month low of $80.03 and a twelve month high of $109.30. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. The stock has a market cap of $71.51 billion, a PE ratio of 25.08, a PEG ratio of 3.62 and a beta of 0.44. The firm has a 50-day simple moving average of $92.07 and a 200 day simple moving average of $97.65.

Colgate-Palmolive Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be given a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 2.28%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 57.31%.

Analysts Set New Price Targets

CL has been the subject of a number of research reports. Barclays dropped their price objective on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research note on Friday, January 17th. Stifel Nicolaus dropped their price objective on Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating on the stock in a report on Friday, January 17th. Wells Fargo & Company decreased their price objective on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research report on Tuesday, January 7th. StockNews.com cut Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. Finally, Piper Sandler dropped their price objective on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research note on Monday, January 6th. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $101.11.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.